282
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation

ORCID Icon, & ORCID Icon
Pages 21-27 | Received 25 Sep 2023, Accepted 13 Nov 2023, Published online: 07 Dec 2023

References

  • Ensslin CJ , Hibler BP , Lee EH , Nehal KS , Busam KJ , Rossi AM . Atypical Melanocytic Proliferations: A Review of the Literature. Dermatol. Surg. 44(2), 159–174 (2018).
  • Elder DE , Xu X . The approach to the patient with a difficult melanocytic lesion. Pathology 36(5), 428–434 (2004).
  • Elmore JG , Barnhill RL , Elder DE et al. Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ 357, j2813 (2017).
  • AUC Committee Members , Fung MA , Vidal CI et al. Appropriate use criteria for ancillary diagnostic testing in dermatopathology: new recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee. J Cutan Pathol 49(3), 231–245 (2022).
  • Saleem A , Narala S , Raghavan SS . Immunohistochemistry in melanocytic lesions: updates with a practical review for pathologists. Semin. Diagn. Pathol., S0740-2570(21)00096–4 (2022).
  • Lezcano C , Jungbluth AA , Nehal KS , Hollmann TJ , Busam KJ . PRAME Expression in Melanocytic Tumors. The American Journal of Surgical Pathology 42(11), 1456–1465 (2018).
  • Lezcano C , Jungbluth AA , Busam KJ . PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions. Surgical Pathology Clinics 14(2), 165–175 (2021).
  • Lezcano C , Jungbluth AA , Busam KJ . Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors. Am. J. Surg. Pathol. 44(7), 893–900 (2020).
  • Kunc M , Żemierowska N , Skowronek F , Biernat W . Diagnostic test accuracy meta-analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions. Histopathology 83(1), 3–14 (2023).
  • O’Connor MK , Dai H , Fraga GR . PRAME immunohistochemistry for melanoma diagnosis: a STARD-compliant diagnostic accuracy study. J Cutan Pathol 49(9), 780–786 (2022).
  • Swetter SM . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Melanoma: Cutaneous V.3.2023. © National Comprehensive Cancer Network, Inc. (2023). www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf
  • Swetter SM , Tsao H , Bichakjian CK et al. Guidelines of care for the management of primary cutaneous melanoma. J. Am. Acad. Dermatol. 80(1), 208–250 (2019).
  • Clarke LE , Warf MB , Flake DD et al. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol 42(4), 244–252 (2015).
  • Warf MB , Flake DD , Adams D et al. Analytical validation of a melanoma diagnostic gene signature using formalin-fixed paraffin-embedded melanocytic lesions. Biomarkers in Medicine 9(5), 407–416 (2015).
  • Clarke LE , Flake DD , Busam K et al. An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi. Cancer 123(4), 617–628 (2017).
  • Ko JS , Matharoo-Ball B , Billings SD et al. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes. Cancer Epidemiol. Biomarkers Prev. 26(7), 1107–1113 (2017).
  • Clarke LE , Mabey B , Flake II DD et al. Clinical validity of a gene expression signature in diagnostically uncertain neoplasms. Personalized Medicine 17(5), 361–371 (2020).
  • Ko JS , Clarke LE , Minca EC , Brown K , Flake DD , Billings SD . Correlation of melanoma gene expression score with clinical outcomes on a series of melanocytic lesions. Hum. Pathol. 86, 213–221 (2019).
  • Yang X , Karapetyan L , Huang Z et al. Multiple primary melanoma in association with other personal and familial cancers. Cancer Med, E-pub Aug 5 2022 (2022).
  • Antúnez-Lay A , Podlipnik S , Carrera C et al. Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes. J Eur Acad Dermatol Venereol, (2022).
  • Gershenwald JE , Scolyer RA . Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann. Surg. Oncol. 25(8), 2105–2110 (2018).
  • Cockerell CJ , Tschen J , Evans B et al. The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists. Medicine 95(40), e4887 (2016).
  • Castillo SA , Pham AK , Barton DT et al. A diagnostically-challenging case of melanoma ex blue nevus with comprehensive molecular analysis, including the 23-gene expression signature (myPath melanoma). J Cutan Pathol 46(3), 226–230 (2019).
  • Gronbeck C , Rabinovitz H , Np MO , Grant-Kels JM . Concordance of reflectance confocal microscopy and gene expression profiling for melanocytic lesions with uncertain malignant potential: a case series. J Cutan Pathol 50(7), 623–628 (2023).
  • Cho-Vega JH , Cao T , Ledon J et al. Diagnostic application of cyclin D1 fluorescent in situ hybridization for histologically undetermined early lesions of acral melanoma in situ: a case series. Ann Diagn Pathol 50, 151681 (2021).
  • Boothby-Shoemaker W , Kwa M , Kohen L , Shaw B , Friedman BJ . A Rare Case of Primary Cutaneous Signet-Ring Cell Melanoma With Discrepant Findings on Gene Expression Profiling and Chromosomal Microarray Analysis. Am. J. Dermatopathol. 44(7), e79–e82 (2022).
  • Cockerell C , Tschen J , Billings SD et al. The influence of a gene-expression signature on the treatment of diagnostically challenging melanocytic lesions. Personalized Medicine 14(2), 123–130 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.